FBXO31 inhibits the stemness characteristics of CD147 (+) melanoma stem cells

Jian Guan1,2, Shenglin Wu3, Renyi Liang4

  • 1Graduate School, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053, China.

Open Life Sciences
|August 18, 2025
PubMed

Insights

FBXO31 suppresses melanoma stem cell migration, invasion, and stemness. This finding is crucial for understanding and potentially preventing malignant cancer development by targeting melanoma stem cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Stem Cell Research

Background:

  • Melanoma stem cells drive cancer progression.
  • Identifying factors regulating melanoma stem cell properties is critical for therapeutic strategies.

Purpose of the Study:

  • To investigate the role of FBXO31 in regulating the stemness, invasion, and migration of melanoma stem cells.
  • To elucidate the relationship between FBXO31 and CD147 expression in melanoma stem cells.

Main Methods:

  • Isolation of melanoma stem cells (SP cells) from A375 cells.
  • Detection of FBXO31 expression and manipulation via transfection.
  • Flow cytometry to assess CD147 expression.
  • In vitro assays for spheroid formation, migration, and invasion.
  • In vivo studies in nude mice to evaluate tumor growth and metastasis.

Main Results:

  • FBXO31 expression was found to be downregulated in melanoma stem cells.
  • FBXO31 transfection reduced the proportion of CD147-positive cells.
  • CD147-positive cells exhibited enhanced stemness, migration, and invasion, which were suppressed by FBXO31.
  • In vivo experiments confirmed that FBXO31 inhibits tumor growth and metastasis driven by CD147-positive cells.

Conclusions:

  • FBXO31 plays an inhibitory role in the migration, invasion, and stemness of CD147-positive melanoma stem cells.
  • Targeting FBXO31 may represent a potential therapeutic approach for melanoma treatment by reducing cancer stem cell activity.